All of Us study uncovers thousands of novel pharmacogenomic variants in diverse cohort

A study of nearly 100,000 diverse Americans identified thousands of new genetic variants in drug-response genes, expanding the pharmacogenomic variant catalog. The findings improve understanding of population-specific drug metabolism and adverse reaction risks, though clinical translation remains uncertain. This matters for precision medicine and drug development, but has no immediate market impact.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works